Ozempic, Wegovy, and Saxenda are under investigation by the European Medicines Agency for possibly causing consumers to self-harm or experience suicidal thoughts. Clinical trials of the drug did not see this to be a large risk factor, but experts note a changing population of those taking the drugs may have shifted risk levels.
FDA Is Monitoring International Probes into Novo, Lilly Obesity Drugs bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Novo Nordisk Obesity Drugs Probed by UK Regulator Over Suicidal Thoughts bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.